Spiegel Robert J.
Insider CIK 1492256 · PTCT Chief Medical Officer · ADXS Director · CYCC Director · TLON Director · ATNX Director · SCMP Director · EDGE Director · RNXT Director · AYLA Director · GERN Director · CAPS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNXT RenovoRx, Inc. | A Award deriv | 2026-10-01 | 2026-10-02 | 55,924 | — | $0 | 55,924 | SEC↗ |
| GERN GERON CORP | A Award | 2026-09-30 | 2026-10-01 | 6,351 | $1.23 | $7.8K | 212,161 | SEC↗ |
| GERN GERON CORP | A Award | 2026-06-30 | 2026-07-01 | 6,103 | $1.28 | $7.8K | 205,810 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2026-05-20 | 2026-05-26 | 220,000 | — | $0 | 220,000 | SEC↗ |
| GERN GERON CORP | A Award | 2026-03-31 | 2026-04-01 | 5,243 | $1.49 | $7.8K | 199,707 | SEC↗ |
| GERN GERON CORP | A Award | 2025-12-31 | 2026-01-05 | 5,918 | $1.32 | $7.8K | 194,464 | SEC↗ |
| RNXT RenovoRx, Inc. | A Award deriv | 2025-10-01 | 2025-10-02 | 47,640 | — | $0 | 47,640 | SEC↗ |
| GERN GERON CORP | A Award | 2025-09-30 | 2025-10-01 | 5,702 | $1.37 | $7.8K | 188,546 | SEC↗ |
| GERN GERON CORP | A Award | 2025-06-30 | 2025-07-01 | 5,540 | $1.41 | $7.8K | 182,844 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-05-21 | 2025-05-22 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GERN GERON CORP | A Award | 2025-03-31 | 2025-04-02 | 4,913 | $1.59 | $7.8K | 177,304 | SEC↗ |
| GERN GERON CORP | A Award | 2024-12-31 | 2025-04-02 | 2,206 | $3.54 | $7.8K | 172,391 | SEC↗ |
| GERN GERON CORP | A Award | 2024-12-31 | 2025-01-02 | 2,206 | — | $0 | 172,391 | SEC↗ |
| RNXT RenovoRx, Inc. | A Award deriv | 2024-10-01 | 2024-10-02 | 25,099 | — | $0 | 25,099 | SEC↗ |
| GERN GERON CORP | A Award | 2024-09-30 | 2025-04-02 | 1,767 | $4.54 | $8.0K | 170,185 | SEC↗ |
| GERN GERON CORP | A Award | 2024-09-30 | 2024-10-01 | 1,767 | — | $0 | 170,185 | SEC↗ |
| GERN GERON CORP | A Award | 2024-06-28 | 2025-04-02 | 1,916 | $4.24 | $8.1K | 168,418 | SEC↗ |
| GERN GERON CORP | A Award | 2024-06-28 | 2024-06-28 | 1,916 | — | $0 | 168,418 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-05-09 | 2024-05-10 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GERN GERON CORP | A Award | 2024-03-29 | 2025-04-02 | 2,462 | $3.30 | $8.1K | 166,502 | SEC↗ |
| GERN GERON CORP | A Award | 2024-03-29 | 2024-06-28 | 2,462 | — | $0 | 166,502 | SEC↗ |
| RNXT RenovoRx, Inc. | P Buy deriv | 2024-01-26 | 2024-01-30 | 40,983 | — | $0 | 40,983 | SEC↗ |
| RNXT RenovoRx, Inc. | P Buy | 2024-01-26 | 2024-01-30 | 40,983 | — | $0 | 40,983 | SEC↗ |
| GERN GERON CORP | A Award | 2023-12-29 | 2024-01-03 | 3,406 | — | $0 | 164,040 | SEC↗ |
| RNXT RenovoRx, Inc. | A Award deriv | 2023-10-01 | 2023-10-02 | 25,099 | — | $0 | 25,099 | SEC↗ |
| GERN GERON CORP | A Award | 2023-09-29 | 2023-10-02 | 3,390 | — | $0 | 160,634 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2023-06-30 | 2023-07-03 | 42,438 | — | $0 | 42,438 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2023-06-30 | 2023-07-03 | 21,219 | — | $0 | 39,415 | SEC↗ |
| GERN GERON CORP | A Award | 2023-06-30 | 2023-06-30 | 2,239 | — | $0 | 157,244 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-05-31 | 2023-06-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RNXT RenovoRx, Inc. | A Award deriv | 2023-04-25 | 2023-04-27 | 43,026 | — | $0 | 43,026 | SEC↗ |
| ATNX Athenex, Inc. | A Award | 2023-04-21 | 2023-04-24 | 2,300 | $1.31 | $3.0K | 4,592 | SEC↗ |
| GERN GERON CORP | A Award | 2023-03-31 | 2023-04-03 | 3,312 | — | $0 | 155,005 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 2,342 | — | $0 | 2,342 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 1,171 | — | $0 | 1,171 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 1,171 | — | $0 | 1,171 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 3,279 | — | $0 | 3,279 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 17,500 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| ATNX Athenex, Inc. | A Award | 2023-01-13 | 2023-01-17 | 16,130 | $0.19 | $3.1K | 45,830 | SEC↗ |
| GERN GERON CORP | A Award | 2022-12-30 | 2023-01-03 | 2,970 | — | $0 | 151,693 | SEC↗ |
| ATNX Athenex, Inc. | A Award | 2022-10-07 | 2022-10-12 | 12,453 | $0.24 | $3.0K | 29,700 | SEC↗ |
| GERN GERON CORP | A Award | 2022-09-30 | 2022-10-03 | 3,071 | — | $0 | 148,723 | SEC↗ |
| ATNX Athenex, Inc. | M Exercise deriv | 2022-08-03 | 2022-08-30 | 8,750 | — | $0 | 0 | SEC↗ |
| ATNX Athenex, Inc. | M Exercise | 2022-08-03 | 2022-08-30 | 8,750 | — | $0 | 17,247 | SEC↗ |
| ATNX Athenex, Inc. | A Award | 2022-07-20 | 2022-07-21 | 4,508 | $0.67 | $3.0K | 8,497 | SEC↗ |
| GERN GERON CORP | A Award | 2022-06-30 | 2022-07-01 | 4,637 | — | $0 | 145,652 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2022-06-28 | 2022-06-29 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2022-06-14 | 2022-06-16 | 31,645 | — | $0 | 31,645 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2022-06-14 | 2022-06-16 | 15,822 | — | $0 | 18,196 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2022-06-13 | 2022-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2022-05-10 | 2022-05-11 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ATNX Athenex, Inc. | A Award | 2022-04-08 | 2022-04-11 | 3,989 | $0.75 | $3.0K | 3,989 | SEC↗ |
| GERN GERON CORP | A Award | 2022-03-31 | 2022-04-01 | 5,284 | — | $0 | 141,015 | SEC↗ |
| GERN GERON CORP | A Award | 2021-12-31 | 2022-01-03 | 5,891 | — | $0 | 135,731 | SEC↗ |
| GERN GERON CORP | A Award | 2021-09-30 | 2021-10-01 | 5,246 | — | $0 | 129,840 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 8,750 | — | $0 | 8,750 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 8,750 | — | $0 | 8,750 | SEC↗ |
| GERN GERON CORP | A Award | 2021-06-30 | 2021-07-01 | 5,097 | — | $0 | 124,594 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-06-15 | 2021-06-17 | 4,748 | — | $0 | 4,748 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2021-06-15 | 2021-06-17 | 2,374 | — | $0 | 2,374 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2021-06-10 | 2021-06-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2021-05-11 | 2021-05-13 | 83,000 | — | $0 | 83,000 | SEC↗ |
| GERN GERON CORP | A Award | 2021-03-31 | 2021-04-02 | 4,549 | — | $0 | 119,497 | SEC↗ |
| GERN GERON CORP | A Award | 2020-12-31 | 2021-01-11 | 4,520 | — | $0 | 114,948 | SEC↗ |
| GERN GERON CORP | A Award | 2020-09-30 | 2020-10-02 | 4,130 | — | $0 | 110,428 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2020-08-05 | 2020-08-12 | 7,292 | — | $0 | 7,292 | SEC↗ |
| GERN GERON CORP | A Award | 2020-06-30 | 2020-07-02 | 3,297 | — | $0 | 106,298 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2020-06-25 | 2020-06-29 | 5,200 | — | $0 | 5,200 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2020-06-05 | 2020-06-09 | 83,000 | — | $0 | 83,000 | SEC↗ |
| GERN GERON CORP | A Award | 2020-03-31 | 2020-04-01 | 6,039 | — | $0 | 103,001 | SEC↗ |
| GERN GERON CORP | A Award | 2019-12-31 | 2020-01-03 | 5,284 | — | $0 | 96,962 | SEC↗ |
| GERN GERON CORP | A Award | 2019-09-30 | 2019-10-01 | 5,404 | — | $0 | 91,678 | SEC↗ |
| GERN GERON CORP | A Award | 2019-06-28 | 2019-07-01 | 5,097 | — | $0 | 86,274 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2019-06-06 | 2019-06-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-05-29 | 2019-05-31 | 18,750 | — | $0 | 18,750 | SEC↗ |
| GERN GERON CORP | A Award | 2019-03-29 | 2019-04-01 | 4,329 | — | $0 | 81,177 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 48,661 | SEC↗ |
| GERN GERON CORP | A Award | 2018-12-31 | 2019-01-02 | 7,188 | — | $0 | 76,848 | SEC↗ |
| GERN GERON CORP | A Award | 2018-09-28 | 2018-09-28 | 4,084 | — | $0 | 69,660 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2018-09-13 | 2018-09-13 | 35,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2018-09-13 | 2018-09-13 | 35,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2018-09-13 | 2018-09-13 | 35,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2018-09-13 | 2018-09-13 | 15,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2018-09-13 | 2018-09-13 | 10,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2018-09-13 | 2018-09-13 | 45,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2018-09-13 | 2018-09-13 | 45,000 | $5.29 | $238.1K | 110,576 | SEC↗ |
| GERN GERON CORP | S Sale | 2018-09-13 | 2018-09-13 | 45,000 | $6.85 | $308.3K | 65,576 | SEC↗ |
| GERN GERON CORP | S Sale | 2018-09-13 | 2018-09-13 | 10,000 | $6.85 | $68.5K | 65,576 | SEC↗ |
| GERN GERON CORP | M Exercise | 2018-09-13 | 2018-09-13 | 15,000 | $4.91 | $73.7K | 80,576 | SEC↗ |
| GERN GERON CORP | S Sale | 2018-09-13 | 2018-09-13 | 15,000 | $6.85 | $102.8K | 65,576 | SEC↗ |
| GERN GERON CORP | M Exercise | 2018-09-13 | 2018-09-13 | 35,000 | $1.41 | $49.4K | 100,576 | SEC↗ |
| GERN GERON CORP | S Sale | 2018-09-13 | 2018-09-13 | 35,000 | $6.85 | $239.8K | 65,576 | SEC↗ |
| GERN GERON CORP | M Exercise | 2018-09-13 | 2018-09-13 | 35,000 | $1.10 | $38.5K | 100,576 | SEC↗ |
| GERN GERON CORP | S Sale | 2018-09-13 | 2018-09-13 | 35,000 | $6.85 | $239.8K | 65,576 | SEC↗ |
| GERN GERON CORP | M Exercise | 2018-09-13 | 2018-09-13 | 35,000 | $1.94 | $67.9K | 100,576 | SEC↗ |
| GERN GERON CORP | S Sale | 2018-09-13 | 2018-09-13 | 35,000 | $6.85 | $239.8K | 65,576 | SEC↗ |
| GERN GERON CORP | M Exercise | 2018-09-13 | 2018-09-13 | 10,000 | $4.91 | $49.1K | 75,576 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2018-09-06 | 2018-09-10 | 8,576 | — | $0 | 8,576 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GERN GERON CORP | A Award | 2018-06-29 | 2018-07-02 | 2,095 | — | $0 | 65,576 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2018-05-15 | 2018-05-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GERN GERON CORP | A Award | 2018-03-29 | 2018-03-30 | 1,691 | — | $0 | 63,481 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 10,000 | $7.70 | $77.0K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 20,000 | $1.77 | $35.4K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 30,000 | $3.96 | $118.8K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer | 2018-02-13 | 2018-02-13 | 5,130 | $18.00 | $92.3K | 0 | SEC↗ |
| GERN GERON CORP | A Award | 2017-12-29 | 2018-01-02 | 3,993 | — | $0 | 61,790 | SEC↗ |
| GERN GERON CORP | A Award | 2017-09-29 | 2017-10-02 | 3,297 | — | $0 | 57,797 | SEC↗ |
| GERN GERON CORP | A Award | 2017-06-30 | 2017-06-30 | 2,595 | — | $0 | 54,500 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-21 | 15,000 | $10.15 | $152.3K | 15,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-06-01 | 2017-06-05 | 10,000 | — | $0 | 60,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-01 | 2017-06-05 | 5,130 | — | $0 | 14,930 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2017-05-09 | 2017-05-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GERN GERON CORP | A Award | 2017-03-31 | 2017-03-31 | 3,166 | — | $0 | 51,905 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-06-02 | 2016-06-06 | 9,800 | — | $0 | 9,800 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2016-05-17 | 2016-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 32,258 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 14,409 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-08 | 3,000 | $11.00 | $33.0K | 37,112 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 10,533 | — | $0 | 34,112 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 23,579 | — | $0 | 23,579 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 1,549 | $7.91 | $12.3K | 38,661 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2015-05-29 | 2015-06-02 | 20,000 | — | $0 | 50,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2015-05-18 | 2015-05-19 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2015-03-13 | 2015-03-13 | 1,028 | $75.10 | $77.2K | 3,241 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2015-03-13 | 2015-03-13 | 2 | $75.95 | $152 | 3,239 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2015-01-16 | 2015-01-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2015-01-02 | 2015-01-02 | 10,000 | $51.00 | $510.0K | 10,000 | SEC↗ |
| GERN GERON CORP | A Award | 2014-12-31 | 2015-01-02 | 2,212 | — | $0 | 48,739 | SEC↗ |
| GERN GERON CORP | D To issuer | 2014-06-30 | 2014-07-02 | 2,500 | — | $0 | 46,527 | SEC↗ |
| GERN GERON CORP | A Award | 2014-06-30 | 2014-07-02 | 4,478 | — | $0 | 49,027 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2014-05-20 | 2014-05-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | A Award | 2014-03-31 | 2014-04-02 | 6,878 | — | $0 | 44,549 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2014-03-13 | 2014-03-14 | 1,186 | $31.75 | $37.7K | 4,269 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2014-02-27 | 2014-02-28 | 150,000 | $33.97 | $5.10M | 150,000 | SEC↗ |
| GERN GERON CORP | A Award | 2013-12-31 | 2014-01-03 | 3,033 | — | $0 | 37,671 | SEC↗ |
| GERN GERON CORP | A Award | 2013-09-30 | 2013-10-01 | 4,291 | — | $0 | 34,638 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 35,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 10,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 35,000 | — | $0 | 0 | SEC↗ |
| TLON Talon Therapeutics, Inc. | D To issuer deriv | 2013-07-17 | 2013-07-18 | 35,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | D To issuer | 2013-07-09 | 2013-07-10 | 45,000 | — | $0 | 30,347 | SEC↗ |
| GERN GERON CORP | D To issuer | 2013-07-09 | 2013-07-10 | 45,000 | — | $0 | 30,347 | SEC↗ |
| GERN GERON CORP | A Award | 2013-06-28 | 2013-07-02 | 4,792 | — | $0 | 75,347 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2013-05-22 | 2013-05-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | A Award | 2013-03-29 | 2013-04-01 | 6,717 | — | $0 | 70,555 | SEC↗ |
| TLON Talon Therapeutics, Inc. | A Award deriv | 2013-01-25 | 2013-01-29 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | A Award | 2012-12-31 | 2013-01-03 | 5,098 | — | $0 | 66,338 | SEC↗ |
| GERN GERON CORP | D To issuer | 2012-12-31 | 2013-01-03 | 2,500 | — | $0 | 63,838 | SEC↗ |
| GERN GERON CORP | A Award | 2012-09-28 | 2012-10-01 | 4,203 | — | $0 | 61,240 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2012-05-17 | 2012-05-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TLON Talon Therapeutics, Inc. | A Award deriv | 2012-02-17 | 2012-02-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CAPS Capstone Therapeutics Corp | A Award deriv | 2012-01-01 | 2012-01-03 | 10,000 | — | $0 | 80,000 | SEC↗ |
| CAPS Capstone Therapeutics Corp | A Award | 2012-01-01 | 2012-01-03 | 10,000 | — | $0 | 10,000 | SEC↗ |